SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-03-080168
Filing Date
2003-11-13
Accepted
2003-11-13 16:21:13
Documents
4
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 377324
3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9193
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9167
5 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 1350 dex321.htm EX-32.1 4867
  Complete submission text file 0001193125-03-080168.txt   402474
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 03998404
SIC: 2836 Biological Products, (No Diagnostic Substances)